Form4insider filings, from the source

SEC Form 4 · accession 0001415889-15-003706

Vistagen Therapeutics, Inc. · VTGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Shawn Singh
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Nov 11, 2015
Accepted (ET)
Nov 13, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant for Common StockF1,F2$10.00Nov 11, 2015D4,017DAug 25, 2008Dec 31, 2016Common Stock4,0170I
Warrant for Common StockF1,F2$7.00Nov 11, 2015A4,017AAug 25, 2008Mar 19, 2019Common Stock4,0174,017I
Warrant for Common StockF1,F2$10.00Nov 11, 2015D1,786DAug 25, 2008Dec 31, 2016Common Stock1,7860I
Warrant for Common StockF1,F2$7.00Nov 11, 2015A1,786AAug 25, 2008Mar 19, 2019Common Stock1,7861,786I
Warrant for Common StockF3$12.80Nov 11, 2015D72,000DApr 1, 2015Mar 3, 2023Common Stock72,0000D
WarrantF3$7.00Nov 11, 2015A72,000AApr 1, 2015Mar 3, 2023Common Stock72,00072,000D
Warrant for Common StockF4,F2$10.00Nov 11, 2015D150,000DJan 11, 2015Jan 11, 2020Common Stock150,0000I
Warrant for Common StockF4,F2$7.00Nov 11, 2015A150,000AJan 11, 2015Jan 11, 2020Common Stock150,000150,000I
Warrant for Common StockF5,F2$9.25Nov 11, 2015D250,000DSep 2, 2015Sep 2, 2020Common Stock250,0000I
Warrant for Common StockF5,F2$7.00Nov 11, 2015A250,000ASep 2, 2015Sep 2, 2020Common Stock250,000250,000I

Explanation of responses